Exact Sciences Corp (EXAS)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$55.50

Buy

$57.64

arrow-down$-1.34 (-2.33%)

Prices updated at 31 May 2025, 00:30 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
NASDAQ
arrow-down-0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Kevin T. Conroy
CEO
Mr. Kevin T. Conroy
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
7,000
Head office
5505 Endeavor Lane
Madison
United States
53719
mobile
+1 608 284-5700
letter
meganjones@exactsciences.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Ms. Leslie L. Trigg
Director
-
Ms. Kimberly J. Popovits
Director
-
Ms. Katherine S. Zanotti
Independent Director
0.09m
Mr. Kevin T. Conroy
Chairman of the Board, President and Chief Executive Officer
1.08m
Mr. Paul J. Clancy, M.B.A.
Independent Director
0.10m
Mr. Daniel Joseph Levangie
Independent Director
0.09m
Mr. Jacob Orville
Executive Vice President and General Manager, Screening
0.62m
Mr. James E. Doyle
Lead Independent Director
0.13m
Mr. D. Scott Coward
Director
0.08m
Ms. Shacey Petrovic
Independent Director
0.09m
Ms. Sarah Condella
Executive Vice President, Human Resources
0.51m
Mr. Michael J. Barber
Independent Director
0.10m
Mr. Brian Baranick
Executive Vice President and General Manager, Precision Oncology
0.60m
Mr. James Herriott
Senior Vice President, General Counsel and Secretary
-
Mr. Aaron Bloomer
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
0.43m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
FMR Inc27,723,546
Fidelity Management and Research Company27,723,546
FMR LLC22,042,464
Capital World Investors17,835,277
Capital Research and Management Company17,834,113

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
14 May 2024-
13 Nov 2024-
08 Oct 2024-
18 Sep 2024-
05 Aug 2024-
05 Aug 2024-
05 Aug 2024-
05 Aug 2024-
05 Aug 2024-
13 Jun 2024-
13 Jun 2024-
13 Jun 2024-
13 Jun 2024-
13 Jun 2024-
13 Jun 2024-
13 Jun 2024-
13 Jun 2024-
30 Apr 2024-
01 May 2024-
01 May 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.